Form 8-K - Current report:
SEC Accession No. 0001493152-24-042071
Filing Date
2024-10-22
Accepted
2024-10-22 16:45:13
Documents
15
Period of Report
2024-10-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43152
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 11033
  Complete submission text file 0001493152-24-042071.txt   283005

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocea-20241016.xsd EX-101.SCH 3509
4 XBRL DEFINITION FILE ocea-20241016_def.xml EX-101.DEF 29931
5 XBRL LABEL FILE ocea-20241016_lab.xml EX-101.LAB 36433
6 XBRL PRESENTATION FILE ocea-20241016_pre.xml EX-101.PRE 26954
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5601
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 241386784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)